









Markets
/
Stocks
/
nasdaq-btsg
/

Brightspring Health Services Inc

BTSG

32.790USD

-1.260-3.70%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

5.92BMarket Cap

45.72P/E TTM



Brightspring Health Services Inc

32.790

-1.260-3.70%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Brightspring Health Services Inc

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing strongly in the stock market, with strong fundamentals and technicals supporting the momentum. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Brightspring Health Services Inc's Score

Industry at a Glance

Industry Ranking

8 / 78

Overall Ranking

63 / 4623

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 13 analysts

Buy

Current Rating

36.125

Target Price

+6.25%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Brightspring Health Services Inc Highlights

StrengthsRisks

BrightSpring Health Services, Inc. provides a home and community-based healthcare services platform. The Company is focused on delivering complementary pharmacy and provider services to complex patients. It delivers services through two reportable segments: Pharmacy Solutions and Provider Services. It provides pharmacy services when and where demanded and as required by customers and patients in their homes and communities, often in coordination with its provider services. It delivers a variety of impactful and valuable provider services to high-need, chronic, and complex patients in home and community settings. Its platform offers complimentary pharmacy and provider services that more completely address the multiple needs of complex senior and specialty patients across their various settings and over time. It is also engaged in providing advance care planning, palliative, and hospice services. It provides comprehensive care and clinical solutions in all 50 states.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 45.93% year-on-year.

Overvalued

The company’s latest PE is 52.60, at a high 3-year percentile range.

Fairly Valued

The company’s latest PE is 52.60, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 201.56M shares, increasing 4.21% quarter-over-quarter.

Held by John Hussman

Star Investor John Hussman holds 42.00K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-29

The company's current financial score is 7.25, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 3.33B, representing a year-over-year increase of 14.70%, while its net profit experienced a year-over-year increase of 778.44%.

Score

Industry at a Glance

Previous score

7.25

Change



Financials

4.30

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.06

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.68

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.21

Key Metrics

Free cash flow

No Data

Brightspring Health Services Inc's Company Valuation

Currency: USD Updated: 2025-10-29

The company’s current valuation score is 6.92, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 52.60, which is 60.63% below the recent high of 84.50 and 592.36% above the recent low of -259.00.

Score

Industry at a Glance

Previous score

6.92

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 8/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-29

The company’s current earnings forecast score is 8.46, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Brightspring Health Services Inc is 37.00, with a high of 42.00 and a low of 28.50.

Score

Industry at a Glance

Previous score

8.46

Change

Support & Resistance

No Data

Analyst Rating

Based on 13 analysts

Buy

Current Rating

36.125

Target Price

+6.09%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Brightspring Health Services Inc

BTSG

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-29

The company’s current price momentum score is 9.59, which is higher than the Healthcare Providers & Services industry's average of 7.13. Sideways: Currently, the stock price is trading between the resistance level at 37.00 and the support level at 29.10, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.73

Change

-0.14

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.290

Buy

RSI(14)

64.398

Neutral

STOCH(KDJ)(9,3,3)

74.321

Sell

ATR(14)

1.447

Low Volatility

CCI(14)

55.076

Neutral

Williams %R

31.180

Buy

TRIX(12,20)

0.856

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

33.640

Sell

MA10

32.709

Buy

MA20

30.916

Buy

MA50

28.131

Buy

MA100

24.773

Buy

MA200

22.485

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 113.78%, representing a quarter-over-quarter increase of 11.58%. The largest institutional shareholder is The Vanguard, holding a total of 9.01M shares, representing 5.00% of shares outstanding, with 63.93% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Kohlberg Kravis Roberts & Co. L.P.

77.10M

-17.07%

Fidelity Management & Research Company LLC

23.31M

-1.17%

The Vanguard Group, Inc.

Star Investors

9.01M

+36.13%

Invesco Advisers, Inc.

8.42M

+47.99%

BlackRock Institutional Trust Company, N.A.

5.47M

+45.02%

AllianceBernstein L.P.

5.45M

+12.11%

T. Rowe Price Investment Management, Inc.

4.89M

-15.23%

Rousseau Jon B

3.64M

-1.41%

T. Rowe Price Associates, Inc.

Star Investors

3.04M

+23.86%

Healthcare Of Ontario Pension Plan

2.96M

+3.75%

Risk Assessment

Currency: USD Updated: 2025-10-29

The company’s current risk assessment score is 6.89, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.